ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,057,022 | -70.5% | 29,650 | -61.8% | 0.00% | -100.0% |
| Q2 2023 | $3,580,933 | +210.4% | 77,627 | +169.8% | 0.00% | – |
| Q1 2023 | $1,153,797 | -19.3% | 28,773 | -6.8% | 0.00% | -100.0% |
| Q4 2022 | $1,429,883 | -1.4% | 30,863 | -11.8% | 0.00% | 0.0% |
| Q3 2022 | $1,450,000 | +118.4% | 35,000 | +214.2% | 0.00% | – |
| Q2 2022 | $664,000 | -78.4% | 11,139 | -73.7% | 0.00% | – |
| Q1 2022 | $3,071,000 | -52.0% | 42,291 | -44.4% | 0.00% | -100.0% |
| Q4 2021 | $6,392,000 | -22.6% | 76,008 | -17.0% | 0.00% | -33.3% |
| Q3 2021 | $8,261,000 | +1.1% | 91,601 | +6.9% | 0.00% | 0.0% |
| Q2 2021 | $8,173,000 | +247.2% | 85,723 | +314.7% | 0.00% | +200.0% |
| Q1 2021 | $2,354,000 | -67.7% | 20,673 | -60.7% | 0.00% | -66.7% |
| Q4 2020 | $7,290,000 | +115.8% | 52,664 | +28.1% | 0.00% | +50.0% |
| Q3 2020 | $3,378,000 | +8.5% | 41,097 | +3.3% | 0.00% | 0.0% |
| Q2 2020 | $3,112,000 | +270.9% | 39,788 | +102.5% | 0.00% | +100.0% |
| Q4 2019 | $839,000 | +89.0% | 19,651 | +89.2% | 0.00% | 0.0% |
| Q3 2019 | $444,000 | -77.3% | 10,385 | -59.4% | 0.00% | -75.0% |
| Q3 2018 | $1,954,000 | +476.4% | 25,602 | +284.9% | 0.00% | +300.0% |
| Q1 2018 | $339,000 | -17.1% | 6,652 | -24.6% | 0.00% | 0.0% |
| Q4 2017 | $409,000 | +9.9% | 8,821 | +26.1% | 0.00% | 0.0% |
| Q3 2017 | $372,000 | -34.5% | 6,993 | -12.6% | 0.00% | -66.7% |
| Q3 2016 | $568,000 | +37.9% | 8,000 | +23.0% | 0.00% | +50.0% |
| Q1 2016 | $412,000 | -38.6% | 6,505 | +8.8% | 0.00% | -50.0% |
| Q4 2015 | $671,000 | -20.2% | 5,981 | -27.2% | 0.00% | -20.0% |
| Q2 2015 | $841,000 | – | 8,211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |